Related Experiment Video
Updated: Jun 23, 2026
06:38
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
[Expression, purification and diagnostic application of EBV TK kinase]
Bin Huang1, Bojun Li, Weimin Zhou
1Institute of Virology, Chinese Academy of Preventive Medicine, Beijing 100052, China.
Summary
Epstein-Barr virus thymidine kinase (EBV TK) kinase shows high specificity and sensitivity for detecting antibodies in nasopharyngeal carcinoma (NPC) patients. This method enables rapid and sensitive early diagnosis of NPC.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Context:
- Nasopharyngeal carcinoma (NPC) diagnosis requires sensitive and rapid methods.
- Early detection of NPC is crucial for effective treatment and improved patient outcomes.
- Epstein-Barr virus (EBV) is strongly associated with NPC, making its components potential diagnostic targets.
Purpose:
- To develop and evaluate a rapid and sensitive diagnostic method for NPC.
- To utilize Epstein-Barr virus thymidine kinase (EBV TK) kinase as a biomarker for NPC detection.
- To assess the specificity and sensitivity of EBV TK kinase in identifying NPC-specific antibodies.
Summary:
- Prokaryotic expression plasmid pRSETTK was constructed to highly express EBV TK kinase in E. coli.
- Western blot confirmed the specificity of TK kinase.
- ELISA using purified TK kinase detected specific IgG antibodies in NPC patient serum with high accuracy (98.0% specificity, 93.4% sensitivity).
Impact:
- The study demonstrates that EBV TK kinase is a highly specific and sensitive biomarker for NPC.
- This finding supports the use of EBV TK kinase in ELISA for early and accurate diagnosis of nasopharyngeal carcinoma.
- The developed method offers a promising tool for improving NPC screening and early detection strategies.
